20 May 2013
Keywords: mgi, file, nausea, drug, after, fda, meeting
Article | 13 May 2002
The USA's MGI Pharma and partner Helsinn Healthcare of Switzerlandhave announced plans to file for approval of palonosetron, their new,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 May 2002
© 2013 thepharmaletter.com